Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
TERARECON, INC.
AMPRONIX

Proton Treatment Center Established in Saudi Arabia

By Medimaging International staff writers
Posted on 15 Feb 2012
A new proton treatment facility is being equipped to provide cutting-edge cancer treatment in Riyadh (Saudi Arabia).

Varian Medical Systems (Palo Alto, CA, USA) has booked a USD 77 million order with Saudi Particle Therapy Centre, LLC to equip a new proton therapy facility at the King Fahd Medical Center (Riyadh, Saudi Arabia). Varian will equip the new center with a ProBeam system for five treatment rooms as well as two TrueBeam medical linear accelerators. Equipment delivery and installation is expected to begin in spring 2013 and patient treatments are scheduled to start in late 2014. The agreement will also include a multiyear service contract that should commence as the installation is completed.

“We are honored to have been selected to supply our equipment and software for this prestigious new facility, which will make life-saving proton therapy treatments available for the first time to cancer patients in this region,” said Tim Guertin, Varian’s chief executive officer. “This is an exciting step forward for our Varian Particle Therapy business.”

Proton therapy makes it possible to treat specific types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The technology can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.

“We believe that more and more proton centers will want to employ the full suite of Varian products and technology for radiotherapy and radiosurgery as well as particle therapy for world-class cancer treatments,” said Mr. Guertin. “The combination of these technologies based on 60 years of innovation puts Varian in a unique position to help advance clinical care for patients around the world.”

Varian is currently installing and commissioning its ProBeam system at the Scripps Proton Center near San Diego (CA, USA). The company has also been selected to provide equipment for new proton therapy centers at the University of Maryland (College Park, USA) and in Mestre (Italy). It has been recognized as the preferred provider for a new center at Emory University (Atlanta, GA, USA).

Related Links:

Varian Medical Systems




RADCAL
SuperSonic Imagine
RTI ELECTRONICS AB

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.